Spain
# |
Name |
Gross Profit Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
98.28%
|
Dec. 31, 2023 | USD 1.51 | -0.07% |
|
Spain |
|
2 |
96.94%
|
Dec. 31, 2023 | USD 1.80 | 0.04% |
|
Spain |
|
3 |
93.92%
|
Dec. 31, 2023 | USD 77.86 | 1.89% |
|
Spain |
|
4 |
88.32%
|
Dec. 31, 2023 | USD 1.87 | 1.16% |
|
Spain |
|
5 |
70.33%
|
Dec. 31, 2023 | USD 3.66 | 0.89% |
|
Spain |
|
6 |
64.52%
|
Dec. 31, 2023 | USD 8.60 | 3.71% |
|
Spain |
|
7 |
35.24%
|
Dec. 31, 2023 | USD 9.29 | 3.24% |
|
Spain |
The Biotechnology company in Spain with the highest Gross Profit Margin is Oryzon Genomics S.A. (MCE: ORY.MC) at 98.28%.
The Biotechnology company in Spain with the lowest Gross Profit Margin is Grifols, S.A. (MCE: GRF.MC) at 35.24%.
The top 10 Biotechnology companies in Spain by Gross Profit Margin are Oryzon Genomics S.A., Pangaea Oncology, S.A., Pharma Mar, S.A., Facephi Biometria, S.A., Atrys Health, S.A., Almirall, S.A. and Grifols, S.A..
The bottom 10 Biotechnology companies in Spain by Gross Profit Margin are Grifols, S.A., Almirall, S.A., Atrys Health, S.A., Facephi Biometria, S.A., Pharma Mar, S.A., Pangaea Oncology, S.A. and Oryzon Genomics S.A..